• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA-E:结构研究揭示的免疫受体功能机制

HLA-E: Immune Receptor Functional Mechanisms Revealed by Structural Studies.

作者信息

Gillespie Geraldine M, Quastel Max N, McMichael Andrew J

机构信息

Nuffield Department of Medicine, Center for Immuno-Oncology, University of Oxford, Oxford, UK.

出版信息

Immunol Rev. 2025 Jan;329(1):e13434. doi: 10.1111/imr.13434.

DOI:10.1111/imr.13434
PMID:39753525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11698700/
Abstract

HLA-E is a nonclassical, nonpolymorphic, class Ib HLA molecule. Its primary function is to present a conserved nonamer peptide, termed VL9, derived from the signal sequence of classical MHC molecules to the NKG2x-CD94 receptors on NK cells and a subset of T lymphocytes. These receptors regulate the function of NK cells, and the importance of this role, which is conserved across mammalian species, probably accounts for the lack of genetic polymorphism. A second minor function is to present other, weaker binding, pathogen-derived peptides to T lymphocytes. Most of these peptides bind suboptimally to HLA-E, but this binding appears to be enabled by the relative stability of peptide-free, but receptive, HLA-E-β2m complexes. This, in turn, may favor nonclassical antigen processing that may be associated with bacteria infected cells. This review explores how the structure of HLA-E, bound to different peptides and then to NKG2-CD94 or T-cell receptors, relates to HLA-E cell biology and immunology. A detailed understanding of this molecule could open up opportunities for development of universal T-cell and NK-cell-based immunotherapies.

摘要

HLA - E是一种非经典、无多态性的Ib类HLA分子。其主要功能是将一种名为VL9的保守九肽(源自经典MHC分子的信号序列)呈递给自然杀伤细胞(NK细胞)和一部分T淋巴细胞表面的NKG2x - CD94受体。这些受体调节NK细胞的功能,这种在哺乳动物物种间保守的作用的重要性,可能解释了其缺乏基因多态性的原因。第二个次要功能是将其他与病原体相关的、结合较弱的肽呈递给T淋巴细胞。这些肽中的大多数与HLA - E的结合并不理想,但这种结合似乎是由无肽但具有反应性的HLA - E - β2m复合物的相对稳定性所促成的。反过来,这可能有利于与细菌感染细胞相关的非经典抗原加工。这篇综述探讨了与不同肽结合,然后与NKG2 - CD94或T细胞受体结合的HLA - E的结构,如何与HLA - E细胞生物学和免疫学相关。对该分子的详细了解可能为开发基于通用T细胞和NK细胞的免疫疗法带来机遇。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/11698700/29377518e8ad/IMR-329-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/11698700/498e3a356d03/IMR-329-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/11698700/cc3ef7d078cc/IMR-329-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/11698700/2c5eaec1334e/IMR-329-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/11698700/29377518e8ad/IMR-329-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/11698700/498e3a356d03/IMR-329-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/11698700/cc3ef7d078cc/IMR-329-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/11698700/2c5eaec1334e/IMR-329-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/11698700/29377518e8ad/IMR-329-0-g002.jpg

相似文献

1
HLA-E: Immune Receptor Functional Mechanisms Revealed by Structural Studies.HLA-E:结构研究揭示的免疫受体功能机制
Immunol Rev. 2025 Jan;329(1):e13434. doi: 10.1111/imr.13434.
2
Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint.靶向氨肽酶ERAP可通过破坏NKG2A-HLA-E抑制性检查点增强抗肿瘤免疫力。
Immunity. 2024 Dec 10;57(12):2863-2878.e12. doi: 10.1016/j.immuni.2024.10.013. Epub 2024 Nov 18.
3
HLA-E/peptide complexes differentially interact with NKG2A/CD94 and T cell receptors.HLA-E/肽复合物与NKG2A/CD94和T细胞受体存在差异相互作用。
J Immunol. 2025 Apr 1;214(4):595-605. doi: 10.1093/jimmun/vkae068.
4
A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b.MHC 类 Ib 分子 Qa-1b 呈递抗原的结构基础。
J Immunol. 2012 Jan 1;188(1):302-10. doi: 10.4049/jimmunol.1102379. Epub 2011 Nov 30.
5
HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.HLA-E 及其结合肽:NK 和 T 细胞亚群的识别。
Curr Pharm Des. 2009;15(28):3336-44. doi: 10.2174/138161209789105207.
6
Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia.在先天免疫和适应性免疫应答之间:NKG2A、NKG2C 和 CD8+T 细胞对 HLA-E 限制的自身肽的识别,这些自身肽是在没有 HLA-Ia 的情况下获得的。
Int J Mol Sci. 2019 Mar 22;20(6):1454. doi: 10.3390/ijms20061454.
7
Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.人巨细胞病毒 UL40 多态性影响自然杀伤细胞对人类白细胞抗原-E(HLA-E)的识别。
J Biol Chem. 2013 Mar 22;288(12):8679-8690. doi: 10.1074/jbc.M112.409672. Epub 2013 Jan 18.
8
Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.抑制性自然杀伤细胞受体CD94/NKG2 - A和激活受体CD94/NKG2 - C与HLA - E结合的动力学及肽依赖性
EMBO J. 1999 Aug 2;18(15):4250-60. doi: 10.1093/emboj/18.15.4250.
9
CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.CD94-NKG2A对与HLA I类前导序列结合的人类白细胞抗原(HLA)-E的识别。
J Exp Med. 2008 Mar 17;205(3):725-35. doi: 10.1084/jem.20072525. Epub 2008 Mar 10.
10
Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics.NKG2x免疫受体与HLA - E配体之间的相互作用表现出重叠的亲和力和热力学特性。
J Immunol. 2005 Mar 1;174(5):2878-84. doi: 10.4049/jimmunol.174.5.2878.

引用本文的文献

1
Targeting MHC-E as a new strategy for vaccines and immunotherapeutics.将MHC-E作为疫苗和免疫疗法的新策略。
Nat Rev Immunol. 2025 Sep 3. doi: 10.1038/s41577-025-01218-6.
2
Immune surveillance of senescent cells in aging and disease.衰老与疾病中衰老细胞的免疫监视
Nat Aging. 2025 Aug;5(8):1415-1424. doi: 10.1038/s43587-025-00910-5. Epub 2025 Aug 14.

本文引用的文献

1
Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies.利用质谱法破译 HLA-E 免疫肽组:通用 mRNA 疫苗和 T 细胞导向免疫疗法的机会。
Front Immunol. 2024 Sep 5;15:1442783. doi: 10.3389/fimmu.2024.1442783. eCollection 2024.
2
Instability of the HLA-E peptidome of HIV presents a major barrier to therapeutic targeting.人类免疫缺陷病毒(HIV)的HLA-E肽组不稳定是治疗靶向的主要障碍。
Mol Ther. 2024 Mar 6;32(3):678-688. doi: 10.1016/j.ymthe.2024.01.010. Epub 2024 Jan 12.
3
High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation.
高通量分析 HLA-E 呈递的 CD94/NKG2x 配体揭示了调节 NK 细胞激活的肽段。
Nat Commun. 2023 Aug 9;14(1):4809. doi: 10.1038/s41467-023-40220-1.
4
HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation.从 COVID-19 恢复期患者中分离出的 HLA-E 限制的 SARS-CoV-2 特异性 T 细胞可抑制病毒复制,尽管 HLA I 类分子下调。
Sci Immunol. 2023 Jun 30;8(84):eabl8881. doi: 10.1126/sciimmunol.abl8881.
5
Allopurinol non-covalently facilitates binding of unconventional peptides to HLA-B*58:01.别嘌醇非共价促进非经典肽与 HLA-B*58:01 的结合。
Sci Rep. 2023 Jun 9;13(1):9373. doi: 10.1038/s41598-023-36293-z.
6
Intracellular trafficking of HLA-E and its regulation.HLA-E 的细胞内转运及其调控。
J Exp Med. 2023 Aug 7;220(8). doi: 10.1084/jem.20221941. Epub 2023 May 4.
7
HLA-E-restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD.HLA-E 限制的免疫反应对于控制 EBV 感染和预防 PTLD 至关重要。
Blood. 2023 Mar 30;141(13):1560-1573. doi: 10.1182/blood.2022017650.
8
Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate species.巨细胞病毒疫苗诱导的非传统 T 细胞启动和 SIV 复制的控制在灵长类动物种间是保守的。
Cell Host Microbe. 2022 Sep 14;30(9):1207-1218.e7. doi: 10.1016/j.chom.2022.07.013. Epub 2022 Aug 17.
9
Myeloid cell tropism enables MHC-E-restricted CD8 T cell priming and vaccine efficacy by the RhCMV/SIV vaccine.髓系细胞嗜性通过 RhCMV/SIV 疫苗促进 MHC-E 限制性 CD8 T 细胞的初始免疫和疫苗效力。
Sci Immunol. 2022 Jun 24;7(72):eabn9301. doi: 10.1126/sciimmunol.abn9301. Epub 2022 Jun 17.
10
Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes.HLA-E 的主要和次要功能取决于肽结合复合物的稳定性和构象。
Cell Rep. 2022 Jun 14;39(11):110959. doi: 10.1016/j.celrep.2022.110959.